Testosterone undecanoate - Zhejiang Xianju Pharmaceutical

Drug Profile

Testosterone undecanoate - Zhejiang Xianju Pharmaceutical

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Zhejiang Xianju Pharmaceutical
  • Developer National Research Institute for Family Planning; University of Washington; Zhejiang Xianju Pharmaceutical
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pregnancy

Most Recent Events

  • 22 Jul 2004 This compound is still in active development
  • 22 Jul 2004 A study has been added to the adverse events and Mens Health therapeutic trials sections
  • 01 Dec 1999 Investigation in Pregnancy (Prevention)/Male contraception in China (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top